Defining and Managing High-Priced Cures: Healthcare Payers’ Opinions
نویسندگان
چکیده
منابع مشابه
Managing new premium-priced medicines in Europe
An issue of growing concern for health policy-makers in Europe is the continuing rise in spending on pharmaceuticals. In OECD countries pharmaceutical expenditure rose by 3.5% per year between 2000 and 2009, and averages 18-19% of total health expenditure [1]. Similar averages are seen across Europe, with pharmaceutical spending representing the largest component of ambulatory care [2]. Spendin...
متن کاملDefining and managing imatinib resistance.
While imatinib is highly effective therapy, with improving prospects over time for sustained remission and potential to severely limit or eliminate disease progression and transformation, a minority of patients either fail or respond suboptimally to imatinib; as well, disease eradication may not be possible with imatinib. Distinct patterns of resistance have evolved with the use of imatinib, an...
متن کاملDefining and managing chronic fatigue syndrome.
Authors' objectives The review covered four research objectives: (1) to find the existing case definitions of chronic fatigue syndrome (CFS) in adults; (2) what case definitions have been substantiated and/or validated in adults; (3) the prevalence and natural history of CFS in adults; and (4) whether there is evidence to show that particular treatments improve clinical symptoms of CFS when com...
متن کاملDefining and managing incidental findings in genetic and genomic practice.
The rapidly declining costs and increasing speeds of whole-genome analysis mean that genetic testing is undergoing a shift from targeted approaches to broader ones that look at the entire genome. As whole-genome technologies gain widespread use, questions about the management of so-called incidental findings-those unrelated to the question being asked-need urgent consideration. In this review, ...
متن کاملResource use and Costs for Managing HCV Genotype 1 Patients in Colombia from the Payers Perspective.
REFERENCES Genotype 1 Hepatitis C Virus (HCV) chronic infection is a public health problem in Colombia. The natural course of the disease generates a significant humanistic and economic burden, especially because of long term medical complication. Unlike other viral diseases which could be prevented through vaccines, the only alternative to avoid further HCV complications is the early detection...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2019
ISSN: 1098-3015
DOI: 10.1016/j.jval.2018.11.012